This analysis sheds light on the growth opportunities for bio-CDMO market participants based on their business models and strategic approaches. It also captures the key developments in this segment, expansions, service offerings, and mergers that will impact overall bio-CDMO growth.
This industry has been exposed to many vulnerabilities due to the pandemic, necessitating the adoption of novel care delivery models. Explore how providers are building alternative sites of care and integrated delivery networks to achieve cost synergies and scale up operations.
The CRO industry experienced sudden growth in 2020 due to the surge in R&D efforts related to COVID-19 therapies and vaccines. This research highlights the major global CROs, new growth patterns, influences and challenges across regions, and clinical development phases.
1.Time for change
2021 will (fingers crossed) go down in history as the year the world started to take climate change seriously. In April, the UK and Chinese governments announced ambitious goals of achieving carbon zero by 2050 and 2060 respectively. America plans to achieve a 50-52% reduction from 2005 levels in economy-wide net greenhouse gas pollution by 2030.
In the corporate world, high-tech businesses such as Microsoft, Apple and Novo Nordisk and service companies such as EY, Sky and KPMG have set their sights on achieving carbon zero by 2030. The more energy intensive industries including manufacturers (Cemex, Holcim and Tetrapak), oil and gas firms (BP, Shell and Total) and airline companies (BA, American Airlines and Japan Airlines) plan to reach this target by 2050.
Schedule a dialog or email us at myfrost@frost.com to connect with an industry expert at no charge. We are taking unprecedented action to make our team available to help you cut through the media and politics to get factual one-to-one guidance for the issues and opportunities that matter most to your business.
The Explosion of Data Accelerates the Growth of the US SDOH Sector
Read more Request Info
IoT-Based Technologies Propel Growth for Home Healthcare Solutions
Read more Request Info
AI-based Image Analysis Tools Propel Growth in the Global Digital Pathology Sector
Read more Request Info
COVID-19 Pandemic Paves Way for New Growth Opportunities in the Virtual Care Sector
Read more Request Info
ROI Streams and Patient-centric Virtual Care Approaches Powering Growth in the Healthcare Industry
Read more Request Info
Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Sector
Read more Request InfoGlobally, Doctor’s Day is celebrated on different dates to applaud the selfless service of the doctors and their role and responsibility in serving lives. In India, the Indian Medical Association (IMA) celebrates 1st July – the birth and death anniversary of Dr. Bidhan Chandra Roy, as National Doctor’s Day. He was a renowned doctor, politician, and philanthropist from the state of West Bengal.
Read more
As the biologics contract development and manufacturing organization (CDMO) market expands at double-digit rates, Thermo Fisher Scientific (TMO) is doubling down on its portfolio again after acquiring Henogen SA (viral vector manufacturer) and Mesa Biotech, Inc. earlier this year. PPD’s acquisition will boost TMO’s position in the CDMO market.
Read more
As professionals, our careers are often assessed on our ability to identify critical technology growth opportunities and mitigate the inherent risk associated with our choices. One important consideration is how these technologies converge to create unique technology profiles that previously would not have been considered.
Read more
Frost & Sullivan’s recent analysis finds that medical technology (MedTech) firms are experiencing a rapid transformation as hospitals gradually move from high-acuity and high-dependency care to decentralized and patient-centric care models. The global MedTech market, comprising traditional MedTech and new value-added business models, is expected to reach $529.23 billion by 2024.
The biopharmaceutical industry is facing its biggest test in recent times. A rise in new disease outbreaks, the urgency to launch innovative therapies, and new constructs such as multi-valent antibodies are compelling biopharmaceutical companies to adopt new manufacturing approaches. The industry must reduce costs and achieve scalability of downstream processes in global sites to work more efficiently.
Frost & Sullivan has identified Palo Alto Networks as a growth and innovation top-performing leader in the Frost Radar™: US Healthcare Cybersecurity Market, 2020. The company’s solutions are used by myriad health systems, ranging from hospitals with a seemingly less complicated mix to integrated delivery networks (IDNs) catering to a complex disease mix and experimental treatment with connected care enablers that drive precision medicine workflows.
Read more
